CEO Total Pay
$17.4M
FY2025 Summary Compensation, well above median
The CEO earned $17.4M in FY2025 against median worker pay of $89,827 · Measuring Instruments.
Data updated August 2026
Subscribe to Edwards Lifesciences Corp CEO pay filing updates (RSS)
Answer first
According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $89,827. Industry placement uses the FY2025 SIC-38 peer cohort (# 25 of 86, 72nd percentile - above the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Measuring Instruments companies.
Edwards Lifesciences Corp CEO pay vs. every FY2025 complete filing
Total CEO compensation, the full national distribution, this company marked
$17,426,438 Top 16% higher than 84% of 1,423 companies
Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025
CEO total pay ($17.4M) against pay ratio (194:1) for Edwards Lifesciences Corp (marked) and its 3 closest same-industry peers, against the Measuring Instruments industry median on both axes.
Exclusive CEO-to-median-worker bands across 80 complete latest-FY filings in SIC 38. Segments sum to the peer set, not this company's compensation pillar.
A component-level pay breakdown is not reported in Edwards Lifesciences Corp's structured SEC pay-ratio disclosure. See our methodology →
Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).
| FY | CEO pay | Δ pay | Median worker | Pay ratio | Δ ratio |
|---|---|---|---|---|---|
| 2021 | $13.6M | - | $73,036 | 186:1 | - |
| 2022 | $14.0M | +2.9% | $50,997 | 274:1 | +88:1 |
| 2023 | $13.3M | -4.5% | $50,368 | 265:1 | -9:1 |
| 2024 | $14.6M | +9.4% | $74,125 | 197:1 | -68:1 |
| 2025 | $17.4M | +19% | $89,827 | 194:1 | -3:1 |
Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1099800, FY2021–2025. Adjacent-year deltas only.
Edwards Lifesciences Corp's FY2025 ratio 194:1 ranks #25 of 86 Measuring Instruments filers (72nd percentile). the CEO earned 194× the median employee ($89,827) in FY2025.
Median employee $89,827 (HIGH-MED); STEEP · PEAK stamps put about 194 median-wage years per CEO year.
CEO Total Pay
$17.4M
FY2025 Summary Compensation, well above median
Pay Ratio
194:1
Elevated vs. peers
Edwards Lifesciences Corp's FY2025 ratio 194:1 ranks #25 of 86 Measuring Instruments filers (72nd percentile). The structured pay-ratio disclosure reports the total without line-item components. Measuring Instruments (SIC 38) median ratio is 121:1 across 86 FY2025 filers; Edwards Lifesciences Corp's $17.4M CEO total is above the $8.0M industry median CEO pay.
Dollar rank #223 and ratio rank #323 split - treat 194:1 as a disclosure, not a fairness score. Open Measuring Instruments peers.
Read our methodology - how this data is sourced, computed, and verified. Edwards Lifesciences Corp's FY2025 ratio 194:1 ranks #25 of 86 Measuring Instruments filers (72nd percentile).
ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps STEEP · PEAK · HIGH-MED.
ABS(ceo_total_comp) peer at $17.4M (Δ $11K lighter vs Edwards Lifesciences Corp); MEGA · LOW-MED vs this page's STEEP · PEAK · HIGH-MED.
ABS(ceo_total_comp) peer at $17.4M (Δ $20K lighter vs Edwards Lifesciences Corp); MEGA · LOW-MED vs this page's STEEP · PEAK · HIGH-MED.
ABS(ceo_total_comp) peer at $17.5M (Δ $31K heavier vs Edwards Lifesciences Corp); STEEP · HIGH-MED vs this page's STEEP · PEAK · HIGH-MED.
ABS(ceo_total_comp) peer at $17.5M (Δ $41K heavier vs Edwards Lifesciences Corp); STEEP · PAR-MED vs this page's STEEP · PEAK · HIGH-MED.
Zimmer Biomet Holdings, Inc. stamps STEEP · PEAK nearest in-SIC by ABS(pay_ratio) to Edwards Lifesciences Corp's STEEP filing.
Edwards Lifesciences Corp's FY2025 package sits #223 by CEO dollars and #323 by ratio under PEAK · STEEP.
Edwards Lifesciences Corp's PEAK CEO total is equity-sensitive - read what grant-date fair value does and does not mean.
Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.